Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

JORGE SERJE

Allopathic & Osteopathic Physicians Internal Medicine

NPI
1285681643
CMS profile
58431
Location
BROOKLYN, NY

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2020 · Entire year

$4,729.28

175 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2020 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $3,282.08 172
Travel and Lodging $1,447.20 3

By paying entity

PY2020 · entire year · sorted by reported total

Page 3 of 4; records 101–150 of 175 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

JORGE SERJE

NPI 1285681643 · CMS profile ID 58431

Allopathic & Osteopathic Physicians / Internal Medicine

BROOKLYN, NY

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2020; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 3 of 4; records 101–150 of 175 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1285681643?year=2020&recipient=provider&page=3#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/a08c4b30-5cf3-4948-ad40-36f404619019

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
JORGE SERJE, NPI 1285681643, CMS profile ID 58431. General Payments, PY2020; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 4; records 101–150 of 175 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1285681643?year=2020&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/a08c4b30-5cf3-4948-ad40-36f404619019.
APA 7
IndustryPayments. (2026). JORGE SERJE, NPI 1285681643, CMS profile ID 58431. General Payments, PY2020; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 4; records 101–150 of 175 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1285681643?year=2020&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/a08c4b30-5cf3-4948-ad40-36f404619019.
Bluebook
JORGE SERJE, NPI 1285681643, CMS profile ID 58431, IndustryPayments, General Payments, PY2020; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 3 of 4; records 101–150 of 175 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/a08c4b30-5cf3-4948-ad40-36f404619019. https://industrypayments.org/provider/npi-1285681643?year=2020&recipient=provider&page=3#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2020

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2020 · Physicians and non-physician practitioners · CMS publication 2026-06-30

175 matching records · $4,729.28 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 175 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 101–150 of 175.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Allergan, Inc. $12.7406/29/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 723320327 CMS
Allergan, Inc. $10.3806/26/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 723320323 CMS
Allergan, Inc. $19.7806/26/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 723320325 CMS
IRONWOOD PHARMACEUTICALS, INC $14.9306/26/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 749791855 CMS
AstraZeneca Pharmaceuticals LP $19.9006/23/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 736214663 CMS
Merck Sharp & Dohme Corporation $18.5306/22/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 747737399 CMS
Lilly USA, LLC $18.3006/19/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 728517057 CMS
Allergan, Inc. $18.7906/18/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 723320321 CMS
Amarin Pharma Inc. $24.9806/16/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 740069355 CMS
SANOFI-AVENTIS U.S. LLC $19.6206/15/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 744094489 CMS
Novo Nordisk Inc $17.7006/12/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 744739475 CMS
Novo Nordisk Inc $13.7806/09/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 744740223 CMS
Allergan, Inc. $14.9806/08/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 723320319 CMS
Allergan, Inc. $22.4006/05/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 723320317 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $23.2806/04/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 720990646 CMS
Allergan, Inc. $14.2405/29/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 723320315 CMS
Novo Nordisk Inc $16.3305/28/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 744703437 CMS
Amarin Pharma Inc. $21.8405/27/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 739929053 CMS
AstraZeneca Pharmaceuticals LP $21.0505/19/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 736301979 CMS
AstraZeneca Pharmaceuticals LP $19.0105/14/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 736077129 CMS
Allergan, Inc. $17.7305/12/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 723320313 CMS
SANOFI-AVENTIS U.S. LLC $17.8505/12/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 744094469 CMS
Allergan, Inc. $22.5304/28/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 723320311 CMS
AstraZeneca Pharmaceuticals LP $19.5304/27/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 736183765 CMS
AstraZeneca Pharmaceuticals LP $18.9204/24/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 735990137 CMS
IRONWOOD PHARMACEUTICALS, INC $17.5004/21/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 749782757 CMS
Allergan, Inc. $20.5104/16/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 723320309 CMS
SANOFI-AVENTIS U.S. LLC $19.6004/13/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 744094483 CMS
Amarin Pharma Inc. $24.9204/09/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 739933977 CMS
AstraZeneca Pharmaceuticals LP $17.8404/07/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 736228603 CMS
Allergan, Inc. $22.2404/06/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 723320307 CMS
Allergan, Inc. $7.2403/31/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 723320305 CMS
Allergan, Inc. $17.5603/26/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 723320303 CMS
AstraZeneca Pharmaceuticals LP $19.2503/25/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 736114989 CMS
Genentech USA, Inc. $15.6103/25/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 743036055 CMS
Novo Nordisk Inc $21.1703/07/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 744590481 CMS
Allergan, Inc. $21.2903/02/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 723320301 CMS
Merck Sharp & Dohme Corporation $15.1402/28/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 747639929 CMS
Lilly USA, LLC $14.5102/27/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 728493371 CMS
Novo Nordisk Inc $14.5802/27/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 750043649 CMS
Novo Nordisk Inc $2.5002/27/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 856603015 CMS
Allergan, Inc. $121.3302/25/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 723320299 CMS
AstraZeneca Pharmaceuticals LP $16.4402/25/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 735909019 CMS
Takeda Pharmaceuticals U.S.A., Inc. $14.9902/21/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 747297449 CMS
Takeda Pharmaceuticals U.S.A., Inc. $14.9902/21/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 747297451 CMS
Takeda Pharmaceuticals U.S.A., Inc. $124.9902/21/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 747297453 CMS
Takeda Pharmaceuticals U.S.A., Inc. $567.8102/21/2020 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 747297455 CMS
Takeda Pharmaceuticals U.S.A., Inc. $120.0002/21/2020 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 747297457 CMS
Takeda Pharmaceuticals U.S.A., Inc. $759.3902/21/2020 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 747297459 CMS
Takeda Pharmaceuticals U.S.A., Inc. $74.9902/21/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 747297461 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $2,535.87 149
PY2020 $4,729.28 175
PY2021 $2,594.97 135
PY2022 $2,186.20 106
PY2023 $1,993.65 94
PY2024 $2,802.87 134
PY2025 $2,020.14 98

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $432,076.85 101
PY2024 Recipient $6,236.00 2
PY2024 Principal investigator $342,862.19 19
PY2023 Principal investigator $165,677.00 9
PY2022 Principal investigator $17,275.65 120
PY2021 Principal investigator $87,397.60 161
PY2020 Principal investigator $92,744.83 118
PY2019 Principal investigator $164,848.28 67

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

101 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Genentech, Inc. $5,013.00 12/30/2025 Non-covered Recipient Entity
ELLIPSIS RESEARCH GROUP LLC
CT-388-104 OW/OB with T2D No dispute reported 06/30/2026 1211602000
Principal investigator 1 Genentech, Inc. $9,162.00 12/26/2025 Non-covered Recipient Entity
ELLIPSIS RESEARCH GROUP LLC
CT-388-104 OW/OB with T2D No dispute reported 06/30/2026 1211602034
Principal investigator 1 Genentech, Inc. $550.00 12/19/2025 Non-covered Recipient Entity
ELLIPSIS RESEARCH GROUP LLC
CT-388-104 OW/OB with T2D No dispute reported 06/30/2026 1211602005
Principal investigator 1 Genentech, Inc. $18,019.00 12/19/2025 Non-covered Recipient Entity
ELLIPSIS RESEARCH GROUP LLC
CT-388-104 OW/OB with T2D No dispute reported 06/30/2026 1211602046
Principal investigator 1 Genentech, Inc. $4,361.00 12/11/2025 Non-covered Recipient Entity
ELLIPSIS RESEARCH GROUP LLC
CT-388-104 OW/OB with T2D No dispute reported 06/30/2026 1211602008
Principal investigator 1 Genentech, Inc. $730.00 12/04/2025 Non-covered Recipient Entity
ELLIPSIS RESEARCH GROUP LLC
CT-388-104 OW/OB with T2D No dispute reported 06/30/2026 1211601996
Principal investigator 1 Genentech, Inc. $760.00 12/04/2025 Non-covered Recipient Entity
ELLIPSIS RESEARCH GROUP LLC
CT-388-104 OW/OB with T2D No dispute reported 06/30/2026 1211602013
Principal investigator 1 Genentech, Inc. $6,216.00 12/04/2025 Non-covered Recipient Entity
ELLIPSIS RESEARCH GROUP LLC
CT-388-104 OW/OB with T2D No dispute reported 06/30/2026 1211602017
Principal investigator 1 Genentech, Inc. $1,798.00 12/04/2025 Non-covered Recipient Entity
ELLIPSIS RESEARCH GROUP LLC
CT-388-104 OW/OB with T2D No dispute reported 06/30/2026 1211602021
Principal investigator 1 Genentech, Inc. $1,087.00 12/04/2025 Non-covered Recipient Entity
ELLIPSIS RESEARCH GROUP LLC
CT-388-104 OW/OB with T2D No dispute reported 06/30/2026 1211602025
Principal investigator 1 Genentech, Inc. $675.00 12/04/2025 Non-covered Recipient Entity
ELLIPSIS RESEARCH GROUP LLC
CT-388-104 OW/OB with T2D No dispute reported 06/30/2026 1211602029
Principal investigator 1 Genentech, Inc. $146.00 12/04/2025 Non-covered Recipient Entity
ELLIPSIS RESEARCH GROUP LLC
CT-388-104 OW/OB with T2D No dispute reported 06/30/2026 1211602038
Principal investigator 1 Genentech, Inc. $29,887.00 12/04/2025 Non-covered Recipient Entity
ELLIPSIS RESEARCH GROUP LLC
CT-388-104 OW/OB with T2D No dispute reported 06/30/2026 1211602042
Principal investigator 1 Genentech, Inc. $550.00 11/26/2025 Non-covered Recipient Entity
ELLIPSIS RESEARCH GROUP LLC
CT-388-104 OW/OB with T2D No dispute reported 06/30/2026 1211601970
Principal investigator 1 Genentech, Inc. $3,067.00 11/20/2025 Non-covered Recipient Entity
ELLIPSIS RESEARCH GROUP LLC
CT-388-104 OW/OB with T2D No dispute reported 06/30/2026 1211601954
Principal investigator 1 Genentech, Inc. $550.00 11/14/2025 Non-covered Recipient Entity
ELLIPSIS RESEARCH GROUP LLC
CT-388-104 OW/OB with T2D No dispute reported 06/30/2026 1211601939
Principal investigator 1 Genentech, Inc. $170.00 11/14/2025 Non-covered Recipient Entity
ELLIPSIS RESEARCH GROUP LLC
CT-388-104 OW/OB with T2D No dispute reported 06/30/2026 1211601942
Principal investigator 1 Genentech, Inc. $153.00 11/14/2025 Non-covered Recipient Entity
ELLIPSIS RESEARCH GROUP LLC
CT-388-104 OW/OB with T2D No dispute reported 06/30/2026 1211601946
Principal investigator 1 Genentech, Inc. $586.00 11/14/2025 Non-covered Recipient Entity
ELLIPSIS RESEARCH GROUP LLC
CT-388-104 OW/OB with T2D No dispute reported 06/30/2026 1211601950
Principal investigator 1 Genentech, Inc. $550.00 11/14/2025 Non-covered Recipient Entity
ELLIPSIS RESEARCH GROUP LLC
CT-388-104 OW/OB with T2D No dispute reported 06/30/2026 1211601963
Principal investigator 1 Genentech, Inc. $8,004.00 11/14/2025 Non-covered Recipient Entity
ELLIPSIS RESEARCH GROUP LLC
CT-388-104 OW/OB with T2D No dispute reported 06/30/2026 1211601966
Principal investigator 1 Genentech, Inc. $1,944.00 11/14/2025 Non-covered Recipient Entity
ELLIPSIS RESEARCH GROUP LLC
CT-388-104 OW/OB with T2D No dispute reported 06/30/2026 1211601974
Principal investigator 1 Genentech, Inc. $4,906.00 11/14/2025 Non-covered Recipient Entity
ELLIPSIS RESEARCH GROUP LLC
CT-388-104 OW/OB with T2D No dispute reported 06/30/2026 1211601979
Principal investigator 1 Genentech, Inc. $3,108.00 11/14/2025 Non-covered Recipient Entity
ELLIPSIS RESEARCH GROUP LLC
CT-388-104 OW/OB with T2D No dispute reported 06/30/2026 1211601983
Principal investigator 1 Genentech, Inc. $85.00 11/14/2025 Non-covered Recipient Entity
ELLIPSIS RESEARCH GROUP LLC
CT-388-104 OW/OB with T2D No dispute reported 06/30/2026 1211601987
Principal investigator 1 Genentech, Inc. $3,108.00 11/14/2025 Non-covered Recipient Entity
ELLIPSIS RESEARCH GROUP LLC
CT-388-104 OW/OB with T2D No dispute reported 06/30/2026 1211601992
Principal investigator 1 Genentech, Inc. $14,032.00 11/06/2025 Non-covered Recipient Entity
ELLIPSIS RESEARCH GROUP LLC
CT-388-104 OW/OB with T2D No dispute reported 06/30/2026 1211601959
Principal investigator 1 Genentech, Inc. $8,720.00 10/29/2025 Non-covered Recipient Entity
ELLIPSIS RESEARCH GROUP LLC
CT-388-104 OW/OB with T2D No dispute reported 06/30/2026 1211601931
Principal investigator 1 Genentech, Inc. $9,191.00 10/24/2025 Non-covered Recipient Entity
ELLIPSIS RESEARCH GROUP LLC
CT-388-104 OW/OB with T2D No dispute reported 06/30/2026 1211601892
Principal investigator 1 Genentech, Inc. $170.00 10/16/2025 Non-covered Recipient Entity
ELLIPSIS RESEARCH GROUP LLC
CT-388-104 OW/OB with T2D No dispute reported 06/30/2026 1211601906
Principal investigator 1 Genentech, Inc. $16,114.00 10/16/2025 Non-covered Recipient Entity
ELLIPSIS RESEARCH GROUP LLC
CT-388-104 OW/OB with T2D No dispute reported 06/30/2026 1211601920
Principal investigator 1 Genentech, Inc. $550.00 10/16/2025 Non-covered Recipient Entity
ELLIPSIS RESEARCH GROUP LLC
CT-388-104 OW/OB with T2D No dispute reported 06/30/2026 1211601924
Principal investigator 1 Genentech, Inc. $8,964.00 10/09/2025 Non-covered Recipient Entity
ELLIPSIS RESEARCH GROUP LLC
CT-388-104 OW/OB with T2D No dispute reported 06/30/2026 1211601914
Principal investigator 1 Genentech, Inc. $3,108.00 10/01/2025 Non-covered Recipient Entity
ELLIPSIS RESEARCH GROUP LLC
CT-388-104 OW/OB with T2D No dispute reported 06/30/2026 1211601898
Principal investigator 1 Genentech, Inc. $647.00 10/01/2025 Non-covered Recipient Entity
ELLIPSIS RESEARCH GROUP LLC
CT-388-104 OW/OB with T2D No dispute reported 06/30/2026 1211601902
Principal investigator 1 Genentech, Inc. $635.00 10/01/2025 Non-covered Recipient Entity
ELLIPSIS RESEARCH GROUP LLC
CT-388-104 OW/OB with T2D No dispute reported 06/30/2026 1211601910
Principal investigator 1 Genentech, Inc. $8,822.00 10/01/2025 Non-covered Recipient Entity
ELLIPSIS RESEARCH GROUP LLC
CT-388-104 OW/OB with T2D No dispute reported 06/30/2026 1211601928
Principal investigator 1 Genentech, Inc. $612.00 10/01/2025 Non-covered Recipient Entity
ELLIPSIS RESEARCH GROUP LLC
CT-388-104 OW/OB with T2D No dispute reported 06/30/2026 1211601935
Principal investigator 1 Genentech, Inc. $8,640.00 09/24/2025 Non-covered Recipient Entity
ELLIPSIS RESEARCH GROUP LLC
CT-388-104 OW/OB with T2D No dispute reported 06/30/2026 1211601753
Principal investigator 1 Genentech, Inc. $15,677.00 09/18/2025 Non-covered Recipient Entity
ELLIPSIS RESEARCH GROUP LLC
CT-388-104 OW/OB with T2D No dispute reported 06/30/2026 1211601802
Principal investigator 1 Genentech, Inc. $14,588.00 09/11/2025 Non-covered Recipient Entity
ELLIPSIS RESEARCH GROUP LLC
CT-388-104 OW/OB with T2D No dispute reported 06/30/2026 1211601865
Principal investigator 1 Genentech, Inc. $8,585.00 09/04/2025 Non-covered Recipient Entity
ELLIPSIS RESEARCH GROUP LLC
CT-388-104 OW/OB with T2D No dispute reported 06/30/2026 1211601848
Principal investigator 1 Genentech, Inc. $85.00 08/26/2025 Non-covered Recipient Entity
ELLIPSIS RESEARCH GROUP LLC
CT-388-104 OW/OB with T2D No dispute reported 06/30/2026 1211601727
Principal investigator 1 Genentech, Inc. $3,108.00 08/26/2025 Non-covered Recipient Entity
ELLIPSIS RESEARCH GROUP LLC
CT-388-104 OW/OB with T2D No dispute reported 06/30/2026 1211601794
Principal investigator 1 Genentech, Inc. $18,931.00 08/26/2025 Non-covered Recipient Entity
ELLIPSIS RESEARCH GROUP LLC
CT-388-104 OW/OB with T2D No dispute reported 06/30/2026 1211601840
Principal investigator 1 Genentech, Inc. $3,108.00 08/26/2025 Non-covered Recipient Entity
ELLIPSIS RESEARCH GROUP LLC
CT-388-104 OW/OB with T2D No dispute reported 06/30/2026 1211601870
Principal investigator 1 Genentech, Inc. $1,148.00 08/21/2025 Non-covered Recipient Entity
ELLIPSIS RESEARCH GROUP LLC
CT-388-104 OW/OB with T2D No dispute reported 06/30/2026 1211601761
Principal investigator 1 Genentech, Inc. $647.00 08/21/2025 Non-covered Recipient Entity
ELLIPSIS RESEARCH GROUP LLC
CT-388-104 OW/OB with T2D No dispute reported 06/30/2026 1211601766
Principal investigator 1 Genentech, Inc. $1,798.00 08/21/2025 Non-covered Recipient Entity
ELLIPSIS RESEARCH GROUP LLC
CT-388-104 OW/OB with T2D No dispute reported 06/30/2026 1211601777
Principal investigator 1 Genentech, Inc. $3,108.00 08/21/2025 Non-covered Recipient Entity
ELLIPSIS RESEARCH GROUP LLC
CT-388-104 OW/OB with T2D No dispute reported 06/30/2026 1211601832
Principal investigator 1 Genentech, Inc. $3,108.00 08/21/2025 Non-covered Recipient Entity
ELLIPSIS RESEARCH GROUP LLC
CT-388-104 OW/OB with T2D No dispute reported 06/30/2026 1211601877
Principal investigator 1 Genentech, Inc. $1,798.00 08/21/2025 Non-covered Recipient Entity
ELLIPSIS RESEARCH GROUP LLC
CT-388-104 OW/OB with T2D No dispute reported 06/30/2026 1211601884
Principal investigator 1 Genentech, Inc. $12,490.00 08/14/2025 Non-covered Recipient Entity
ELLIPSIS RESEARCH GROUP LLC
CT-388-104 OW/OB with T2D No dispute reported 06/30/2026 1211601790
Principal investigator 1 Verona Pharma, Inc. $222.61 08/14/2025 Non-covered Recipient Entity
MEETING PROTOCOL WORLDWIDE LP
A Study to Evaluate VTX2735 in Patients With Cryopyrin-associated Periodic Syndrome (Explore) No dispute reported 06/30/2026 1232892163
Principal investigator 1 Verona Pharma, Inc. $180.00 08/14/2025 Non-covered Recipient Entity
MEETING PROTOCOL WORLDWIDE LP
A Study to Evaluate VTX2735 in Patients With Cryopyrin-associated Periodic Syndrome (Explore) No dispute reported 06/30/2026 1232892165
Principal investigator 1 Verona Pharma, Inc. $324.12 08/14/2025 Non-covered Recipient Entity
MEETING PROTOCOL WORLDWIDE LP
A Study to Evaluate VTX2735 in Patients With Cryopyrin-associated Periodic Syndrome (Explore) No dispute reported 06/30/2026 1232892167
Principal investigator 1 Verona Pharma, Inc. $72.00 08/14/2025 Non-covered Recipient Entity
MEETING PROTOCOL WORLDWIDE LP
A Study to Evaluate VTX2735 in Patients With Cryopyrin-associated Periodic Syndrome (Explore) No dispute reported 06/30/2026 1232892169
Principal investigator 1 Verona Pharma, Inc. $19.50 08/14/2025 Non-covered Recipient Entity
MEETING PROTOCOL WORLDWIDE LP
A Study to Evaluate VTX2735 in Patients With Cryopyrin-associated Periodic Syndrome (Explore) No dispute reported 06/30/2026 1232892171
Principal investigator 1 Verona Pharma, Inc. $76.78 08/14/2025 Non-covered Recipient Entity
MEETING PROTOCOL WORLDWIDE LP
A Study to Evaluate VTX2735 in Patients With Cryopyrin-associated Periodic Syndrome (Explore) No dispute reported 06/30/2026 1232892173
Principal investigator 1 Verona Pharma, Inc. $19.50 08/14/2025 Non-covered Recipient Entity
MEETING PROTOCOL WORLDWIDE LP
A Study to Evaluate VTX2735 in Patients With Cryopyrin-associated Periodic Syndrome (Explore) No dispute reported 06/30/2026 1232892175
Principal investigator 1 Verona Pharma, Inc. $324.12 08/14/2025 Non-covered Recipient Entity
MEETING PROTOCOL WORLDWIDE LP
A Study to Evaluate VTX2735 in Patients With Cryopyrin-associated Periodic Syndrome (Explore) No dispute reported 06/30/2026 1232892177
Principal investigator 1 Verona Pharma, Inc. $50.00 08/14/2025 Non-covered Recipient Entity
MEETING PROTOCOL WORLDWIDE LP
A Study to Evaluate VTX2735 in Patients With Cryopyrin-associated Periodic Syndrome (Explore) No dispute reported 06/30/2026 1232892179
Principal investigator 1 Verona Pharma, Inc. $753.60 08/14/2025 Non-covered Recipient Entity
MEETING PROTOCOL WORLDWIDE LP
A Study to Evaluate VTX2735 in Patients With Cryopyrin-associated Periodic Syndrome (Explore) No dispute reported 06/30/2026 1232892327
Principal investigator 1 Verona Pharma, Inc. $29.98 08/14/2025 Non-covered Recipient Entity
MEETING PROTOCOL WORLDWIDE LP
A Study to Evaluate VTX2735 in Patients With Cryopyrin-associated Periodic Syndrome (Explore) No dispute reported 06/30/2026 1232892329
Principal investigator 1 Verona Pharma, Inc. $17.57 08/14/2025 Non-covered Recipient Entity
MEETING PROTOCOL WORLDWIDE LP
A Study to Evaluate VTX2735 in Patients With Cryopyrin-associated Periodic Syndrome (Explore) No dispute reported 06/30/2026 1232892331
Principal investigator 1 Verona Pharma, Inc. $17.64 08/14/2025 Non-covered Recipient Entity
MEETING PROTOCOL WORLDWIDE LP
A Study to Evaluate VTX2735 in Patients With Cryopyrin-associated Periodic Syndrome (Explore) No dispute reported 06/30/2026 1232892333
Principal investigator 1 Genentech, Inc. $12,582.00 07/23/2025 Non-covered Recipient Entity
ELLIPSIS RESEARCH GROUP LLC
CT-388-104 OW/OB with T2D No dispute reported 06/30/2026 1211601824
Principal investigator 1 F. Hoffmann-La Roche AG $450.00 07/22/2025 Non-covered Recipient Entity
ELLIPSIS RESEARCH GROUP LLC
CD P3: Double-Blind Induction No dispute reported 06/30/2026 1211601706
Principal investigator 1 F. Hoffmann-La Roche AG $10,050.00 07/22/2025 Non-covered Recipient Entity
ELLIPSIS RESEARCH GROUP LLC
CD P3: Double-Blind Induction No dispute reported 06/30/2026 1211601711
Principal investigator 1 F. Hoffmann-La Roche AG $1,850.00 07/22/2025 Non-covered Recipient Entity
ELLIPSIS RESEARCH GROUP LLC
CD P3: Double-Blind Induction No dispute reported 06/30/2026 1211601714
Principal investigator 1 Genentech, Inc. $1,798.00 07/17/2025 Non-covered Recipient Entity
ELLIPSIS RESEARCH GROUP LLC
CT-388-104 OW/OB with T2D No dispute reported 06/30/2026 1211601741
Principal investigator 1 Genentech, Inc. $3,108.00 07/17/2025 Non-covered Recipient Entity
ELLIPSIS RESEARCH GROUP LLC
CT-388-104 OW/OB with T2D No dispute reported 06/30/2026 1211601820
Principal investigator 1 Genentech, Inc. $1,136.00 07/10/2025 Non-covered Recipient Entity
ELLIPSIS RESEARCH GROUP LLC
CT-388-104 OW/OB with T2D No dispute reported 06/30/2026 1211601736
Principal investigator 1 Genentech, Inc. $1,395.00 07/10/2025 Non-covered Recipient Entity
ELLIPSIS RESEARCH GROUP LLC
CT-388-104 OW/OB with T2D No dispute reported 06/30/2026 1211601758
Principal investigator 1 Genentech, Inc. $3,108.00 07/10/2025 Non-covered Recipient Entity
ELLIPSIS RESEARCH GROUP LLC
CT-388-104 OW/OB with T2D No dispute reported 06/30/2026 1211601770
Principal investigator 1 Genentech, Inc. $146.00 07/10/2025 Non-covered Recipient Entity
ELLIPSIS RESEARCH GROUP LLC
CT-388-104 OW/OB with T2D No dispute reported 06/30/2026 1211601781
Principal investigator 1 Genentech, Inc. $46.00 07/10/2025 Non-covered Recipient Entity
ELLIPSIS RESEARCH GROUP LLC
CT-388-104 OW/OB with T2D No dispute reported 06/30/2026 1211601786
Principal investigator 1 Genentech, Inc. $5,394.00 07/10/2025 Non-covered Recipient Entity
ELLIPSIS RESEARCH GROUP LLC
CT-388-104 OW/OB with T2D No dispute reported 06/30/2026 1211601799
Principal investigator 1 Genentech, Inc. $9,135.00 07/10/2025 Non-covered Recipient Entity
ELLIPSIS RESEARCH GROUP LLC
CT-388-104 OW/OB with T2D No dispute reported 06/30/2026 1211601836
Principal investigator 1 Genentech, Inc. $83.00 07/10/2025 Non-covered Recipient Entity
ELLIPSIS RESEARCH GROUP LLC
CT-388-104 OW/OB with T2D No dispute reported 06/30/2026 1211601843
Principal investigator 1 Genentech, Inc. $9,324.00 07/10/2025 Non-covered Recipient Entity
ELLIPSIS RESEARCH GROUP LLC
CT-388-104 OW/OB with T2D No dispute reported 06/30/2026 1211601857
Principal investigator 1 Genentech, Inc. $182.79 07/10/2025 Non-covered Recipient Entity
ELLIPSIS RESEARCH GROUP LLC
CT-388-104 OW/OB with T2D No dispute reported 06/30/2026 1211601861
Principal investigator 1 Genentech, Inc. $3,108.00 07/10/2025 Non-covered Recipient Entity
ELLIPSIS RESEARCH GROUP LLC
CT-388-104 OW/OB with T2D No dispute reported 06/30/2026 1211601889
Principal investigator 1 Genentech, Inc. $1,588.00 07/03/2025 Non-covered Recipient Entity
ELLIPSIS RESEARCH GROUP LLC
CT-388-104 OW/OB with T2D No dispute reported 06/30/2026 1211601719
Principal investigator 1 Genentech, Inc. $10,050.00 07/03/2025 Non-covered Recipient Entity
ELLIPSIS RESEARCH GROUP LLC
CT-388-104 OW/OB with T2D No dispute reported 06/30/2026 1211601723
Principal investigator 1 Genentech, Inc. $930.00 07/03/2025 Non-covered Recipient Entity
ELLIPSIS RESEARCH GROUP LLC
CT-388-104 OW/OB with T2D No dispute reported 06/30/2026 1211601731
Principal investigator 1 Genentech, Inc. $8,688.00 07/03/2025 Non-covered Recipient Entity
ELLIPSIS RESEARCH GROUP LLC
CT-388-104 OW/OB with T2D No dispute reported 06/30/2026 1211601746
Principal investigator 1 Genentech, Inc. $150.00 07/03/2025 Non-covered Recipient Entity
ELLIPSIS RESEARCH GROUP LLC
CT-388-104 OW/OB with T2D No dispute reported 06/30/2026 1211601773
Principal investigator 1 Genentech, Inc. $1,850.00 07/03/2025 Non-covered Recipient Entity
ELLIPSIS RESEARCH GROUP LLC
CT-388-104 OW/OB with T2D No dispute reported 06/30/2026 1211601807
Principal investigator 1 Genentech, Inc. $146.00 07/03/2025 Non-covered Recipient Entity
ELLIPSIS RESEARCH GROUP LLC
CT-388-104 OW/OB with T2D No dispute reported 06/30/2026 1211601812
Principal investigator 1 Genentech, Inc. $586.00 07/03/2025 Non-covered Recipient Entity
ELLIPSIS RESEARCH GROUP LLC
CT-388-104 OW/OB with T2D No dispute reported 06/30/2026 1211601816
Principal investigator 1 Genentech, Inc. $1,800.00 07/03/2025 Non-covered Recipient Entity
ELLIPSIS RESEARCH GROUP LLC
CT-388-104 OW/OB with T2D No dispute reported 06/30/2026 1211601828
Principal investigator 1 Genentech, Inc. $3,108.00 07/03/2025 Non-covered Recipient Entity
ELLIPSIS RESEARCH GROUP LLC
CT-388-104 OW/OB with T2D No dispute reported 06/30/2026 1211601852
Principal investigator 1 Genentech, Inc. $3,108.00 07/03/2025 Non-covered Recipient Entity
ELLIPSIS RESEARCH GROUP LLC
CT-388-104 OW/OB with T2D No dispute reported 06/30/2026 1211601873
Principal investigator 1 Genentech, Inc. $146.00 07/03/2025 Non-covered Recipient Entity
ELLIPSIS RESEARCH GROUP LLC
CT-388-104 OW/OB with T2D No dispute reported 06/30/2026 1211601881
Principal investigator 1 Exact Sciences Corporation $2,880.00 02/26/2025 Non-covered Recipient Entity
ELLIPSIS RESEARCH GROUP LLC
Informed Choice Intervention for Colorectal Cancer Screening: COMPASS No dispute reported 06/30/2026 1244037743
Principal investigator 1 Exact Sciences Corporation $3,648.00 01/22/2025 Non-covered Recipient Entity
ELLIPSIS RESEARCH GROUP LLC
Informed Choice Intervention for Colorectal Cancer Screening: COMPASS No dispute reported 06/30/2026 1244037739
Principal investigator 1 Eli Lilly and Company $10,124.11 01/21/2025 Non-covered Recipient Entity
TOTAL MEDICAL CARE
A STUDY OF ORFORGLIPRON (LY3502970) IN ADULT PARTICIPANTS WITH TYPE 2 DIABETES AND INADEQUATE GLYCEMIC CONTROL WITH DIET AND EXERCISE ALONE (ACHIEVE-1) No dispute reported 06/30/2026 1187891922
Principal investigator 1 Eli Lilly and Company $399.51 01/15/2025 Non-covered Recipient Entity
ATLANTA CARDIOLOGY ASSOCIATES LLC
A STUDY OF ORFORGLIPRON (LY3502970) IN ADULT PARTICIPANTS WITH TYPE 2 DIABETES AND INADEQUATE GLYCEMIC CONTROL WITH DIET AND EXERCISE ALONE (ACHIEVE-1) No dispute reported 06/30/2026 1187875273
Principal investigator 1 Eli Lilly and Company $1,135.23 01/14/2025 Non-covered Recipient Entity
ADVANCED MEDICAL RESEARCH INC
A PHASE 3, RANDOMIZED, OPEN-LABEL STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF ONCE DAILY ORAL LY3502970 COMPARED WITH ORAL SEMAGLUTIDE IN ADULT PARTICIPANTS WITH TYPE 2 DIABETES AND INADEQUATE GLYCEMIC CONTROL WITH METFORMIN (ACHIEVE-3) No dispute reported 06/30/2026 1187874125
Principal investigator 1 Eli Lilly and Company $43,167.79 01/13/2025 Non-covered Recipient Entity
TOTAL MEDICAL CARE
A PHASE 3, RANDOMIZED, OPEN-LABEL STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF ONCE DAILY ORAL LY3502970 COMPARED WITH ORAL SEMAGLUTIDE IN ADULT PARTICIPANTS WITH TYPE 2 DIABETES AND INADEQUATE GLYCEMIC CONTROL WITH METFORMIN (ACHIEVE-3) No dispute reported 06/30/2026 1187892858